Core Laboratories N.V. (CLB)

CLB shows strong international demand, free cash flow generation and a solid financial position, but near-term U.S. land activity challenges and margin pressure could limit growth.

Core Laboratories (NYSE: CLB) reported fourth-quarter and full-year 2025 results that reflected modest top-line growth, continued shareholder returns, and a mix of strength in international demand alongside weakness in U.S. land activity. Management emphasized that demand for the company's proprietary technologies helped offset a seasonally soft U.S. land market, while geopolitical tensions, evolving sanctions, and commodity

CLB expects revenues to range from $124 million to $130 million and earnings per share to be between 11 cents and 15 cents for the first quarter of 2026.

Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript

Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago.

FOURTH QUARTER REVENUE OF $138.3 MILLION, UP 3% SEQUENTIALLY AND UP 7% YEAR-OVER-YEAR FOURTH QUARTER OPERATING INCOME OF $15.8 MILLION; EX-ITEMS, $15.7

CLB is expected to report higher revenues than the year-ago period's level. However, it is expected to have faced increased costs and expenses.

Investors interested in Oil and Gas - Field Services stocks are likely familiar with Halliburton (HAL) and Core Laboratories (CLB). But which of these two companies is the best option for those looking for undervalued stocks?

Arkadios Wealth Advisors reduced its holdings in Core Laboratories Inc. (NYSE: CLB) by 41.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 49,297 shares of the oil and gas company's stock after selling 35,599 shares during the period. Arkadios Wealth Advisors owned

CLB shows consistent growth, a strong market position and proprietary tech, but faces challenges like cost pressure, international risks and high valuation concerns.

HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026.

Ariel Investments LLC lifted its position in shares of Core Laboratories Inc. (NYSE: CLB) by 25.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,976,463 shares of the oil and gas company's stock after acquiring an additional 2,634,438 shares

Fisher Asset Management LLC lowered its position in shares of Core Laboratories Inc. (NYSE: CLB) by 14.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 867,726 shares of the oil and gas company's stock after selling 143,838 shares during the

CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties.

Tetra Technologies (NYSE: TTI - Get Free Report) and Core Laboratories (NYSE: CLB - Get Free Report) are both small-cap energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Insider and Institutional Ownership 70.2% of Tetra

Campbell and CO Investment Adviser LLC acquired a new position in shares of Core Laboratories Inc. (NYSE: CLB) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 25,831 shares of the oil and gas company's stock, valued at approximately $298,000. Campbell and CO